Mitchell & Pahl Private Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.04M | Buy |
16,373
+410
| +3% | +$76.1K | 1.34% | 13 |
|
|
2025
Q1 | $3.34M | Sell |
15,963
-415
| -3% | -$87K | 1.56% | 9 |
|
|
2024
Q4 | $2.91M | Buy |
16,378
+588
| +4% | +$104K | 1.36% | 12 |
|
|
2024
Q3 | $3.12M | Sell |
15,790
-22
| -0.1% | -$4.35K | 1.45% | 12 |
|
|
2024
Q2 | $2.71M | Sell |
15,812
-162
| -1% | -$27.8K | 1.43% | 12 |
|
|
2024
Q1 | $2.91M | Buy |
15,974
+62
| +0.4% | +$11.3K | 1.53% | 12 |
|
|
2023
Q4 | $2.47M | Sell |
15,912
-649
| -4% | -$101K | 1.4% | 13 |
|
|
2023
Q3 | $2.47M | Buy |
16,561
+637
| +4% | +$95K | 1.47% | 13 |
|
|
2023
Q2 | $2.15M | Buy |
15,924
+257
| +2% | +$34.6K | 1.29% | 19 |
|
|
2023
Q1 | $2.5M | Buy |
15,667
+376
| +2% | +$59.9K | 1.56% | 11 |
|
|
2022
Q4 | $2.47M | Buy |
15,291
+2
| +0% | +$323 | 1.62% | 11 |
|
|
2022
Q3 | $2.05M | Buy |
15,289
+292
| +2% | +$39.2K | 1.52% | 14 |
|
|
2022
Q2 | $2.3M | Buy |
14,997
+377
| +3% | +$57.7K | 1.6% | 11 |
|
|
2022
Q1 | $2.37M | Buy |
14,620
+180
| +1% | +$29.2K | 1.51% | 12 |
|
|
2021
Q4 | $1.96M | Buy |
14,440
+477
| +3% | +$64.6K | 1.25% | 20 |
|
|
2021
Q3 | $1.51M | Buy |
13,963
+108
| +0.8% | +$11.6K | 1.08% | 27 |
|
|
2021
Q2 | $1.56M | Buy |
13,855
+173
| +1% | +$19.5K | 1.12% | 26 |
|
|
2021
Q1 | $1.48M | Buy |
13,682
+320
| +2% | +$34.6K | 1.15% | 26 |
|
|
2020
Q4 | $1.43M | Buy |
+13,362
| New | +$1.43M | 1.2% | 23 |
|